HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
104.37
+0.09 (0.09%)
Aug 21, 2026, 9:33 AM EDT - Market open

HealthEquity Cash Flow Statement

Millions USD. Fiscal year is Feb - Jan.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Net Income
230.7215.296.755.71-26.14-44.29
Depreciation & Amortization
154.13154.66162.45153.08161.2137.19
Other Amortization
1.091.082.072.853.264.45
Asset Writedown & Restructuring Costs
-----11.25
Loss (Gain) From Sale of Investments
------1.68
Stock-Based Compensation
78.1373.0696.4377.1562.6152.75
Other Operating Activities
48.339.71-11.26-12.84-16.91-20.3
Change in Accounts Receivable
-5.75-5.69-13.11-8.06-9.57-11.2
Change in Accounts Payable
-2.591.718.89-0.2-26.67-2.18
Change in Other Net Operating Assets
-14.14-22.64-2.31-24.872.8715.01
Operating Cash Flow
489.88457.09339.86242.83150.65141
Operating Cash Flow Growth
44.44%34.50%39.96%61.19%6.85%-22.37%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Capital Expenditures
-2.25-1.97-2.08-1.69-3.37-8.91
Cash Acquisitions
------504.53
Sale (Purchase) of Intangibles
-46.68-46.81-503.37-44.38-115.76-128.17
Investment in Securities
-----2.37
Other Investing Activities
4.031.64----
Investing Cash Flow
-44.9-47.14-505.45-46.07-119.13-639.25

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Long-Term Debt Issued
--736.88--950
Long-Term Debt Repaid
--100-561.88-54.38-8.75-1,003
Net Debt Issued (Repaid)
-115-100175-54.38-8.75-53.13
Issuance of Common Stock
10.8711.419.436.476.68466.39
Repurchase of Common Stock
-363.5-299.25-121.49---
Other Financing Activities
0.130.87-5.370.87-0.6-18.41
Financing Cash Flow
-467.51-386.9857.57-47.04-2.67394.86

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Net Cash Flow
-22.5322.98-108.03149.7128.85-103.39

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Free Cash Flow
487.64455.13337.77241.13147.28132.09
Free Cash Flow Growth
44.39%34.74%40.08%63.73%11.50%-21.62%
Free Cash Flow Margin
36.47%34.65%28.15%24.12%17.09%17.46%
Free Cash Flow Per Share
5.635.203.802.771.741.59
Levered Free Cash Flow
370.33338.05-145.32211.8969.6569.7
Unlevered Free Cash Flow
403.53372.68-109.49243.6996.6588.11

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Cash Interest Paid
49.9552.2558.5949.5643.5716.11
Cash Income Tax Paid
7.648.0426.0735.351.53-5.63
Change in Working Capital
-22.48-26.62-6.53-33.13-33.371.63
SEC Filings: 10-K · 10-Q